Euticals to Acquire Archimica Group

The Italian pharma fine chemicals company Euticals will buy Archimica from TowerBrook Capital Parners for an undisclosed sum. Completion of the transaction is expected in early February.

TowerBrook acquired Archimica, a player in the pharmaceutical fine chemicals industry, in June 2006. The company has approximately 550 employees at six production sites in Italy, France, Germany, US and UK and achieved strong sales of €131 million in 2009, a 16% increase from 2008.

Euticals Group is a successful pharmaceuticals fine chemicals company with sales in 2010 of €93 million and five production sites near Milan, Italy. Euticals and Archimica said they expect the combination to be strategic, creating new opportunities to further develop business activities in the fine chemicals sector.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read